- Home
- FOLD vs RUM Comparison
FOLD vs RUM Comparison
Compare FOLD & RUM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOLD
- RUM
- Stock Information
- Founded
- FOLD 2002
- RUM 2013
- Country
- FOLD United States
- RUM United States
- Employees
- FOLD N/A
- RUM 135
- Industry
- FOLD Biotechnology: Pharmaceutical Preparations
- RUM Computer Software: Prepackaged Software
- Sector
- FOLD Health Care
- RUM Technology
- Exchange
- FOLD Nasdaq
- RUM Nasdaq
- Market Cap
- FOLD 2.9B
- RUM 2.7B
- IPO Year
- FOLD 2007
- RUM N/A
- Fundamental
- Price
- FOLD $6.32
- RUM $8.06
- Analyst Decision
- FOLD Strong Buy
- RUM Buy
- Analyst Count
- FOLD 10
- RUM 2
- Target Price
- FOLD $26.89
- RUM $15.00
- AVG Volume (30 Days)
- FOLD 4.2M
- RUM 2.8M
- Earning Date
- FOLD 07-31-2025
- RUM 08-11-2025
- Dividend Yield
- FOLD N/A
- RUM N/A
- EPS Growth
- FOLD N/A
- RUM N/A
- EPS
- FOLD N/A
- RUM N/A
- Revenue
- FOLD $571,160,000.00
- RUM $101,461,524.00
- Revenue This Year
- FOLD $19.97
- RUM $19.22
- Revenue Next Year
- FOLD $22.92
- RUM $36.85
- P/E Ratio
- FOLD N/A
- RUM N/A
- Revenue Growth
- FOLD 32.29
- RUM 25.14
- 52 Week Low
- FOLD $5.51
- RUM $4.92
- 52 Week High
- FOLD $12.65
- RUM $17.40
- Technical
- Relative Strength Index (RSI)
- FOLD 55.44
- RUM 35.99
- Support Level
- FOLD $6.06
- RUM $8.35
- Resistance Level
- FOLD $6.40
- RUM $10.15
- Average True Range (ATR)
- FOLD 0.28
- RUM 0.51
- MACD
- FOLD 0.01
- RUM -0.16
- Stochastic Oscillator
- FOLD 49.44
- RUM 1.67
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.
About RUM Rumble Inc.
Rumble Inc is a free-to-use video-sharing platform where users can watch, share, like, comment, and upload their own videos. Users can subscribe to channels to stay in touch with recent creator content and access video-on-demand uploaded, and live content streamed, by creators. Geographically, it generates a majority of its revenue from the United States.